Synthetic mRNA therapy: Study introduces weapon against metastatic cancer without harmful side effects
Cancer metastasis, the spread of cancer to organs, is a major cause of cancer-related deaths. Once cancer spreads to multiple ...
Hosted on MSN1mon
MAIA’s lung cancer therapy 99% more likely to improve OS over chemo alone
The company added that sequential treatment with THIO followed by PD-1/PD-L1 inhibitors resulted in sustained tumour regression in advanced in vivo cancer models. Now, the company is looking to ...
Gradalis Announces Development of Clinically Relevant Exome Sequencing Bioinformatics Pipeline to Determine Clonal Tumor Mutation Burden
Optimal therapeutic targeting of cancer involves clonal signals which are expressed within all cancer cellsGradalis applies a novel clinically ...
Business Wire19d
MAIA Biotechnology Announces Design for Expansion of THIO-101 Phase 2 Trial in Advanced Non-Small Cell Lung Cancer
The sequential treatment with THIO followed by PD-(L)1 inhibitors resulted in profound and persistent tumor regression in advanced, in vivo cancer models by induction of cancer type–specific ...